Skip Navigation.

Sponsored Projects Administration

Analysis of FDA warning letters reveals patient safety concerns

Published July 10, 2014 by OSP

Analysis of warning letters sent by the Food and Drug Administration over the past 7 years finds that patient safety violations and poor record keeping are common clinical trial concerns.

Read More